CDO1 and glioma: As cysteine catabolism along this metabolic pathway has not been previously studied in the context of tumor biology, as an initial investigation, we tested the hypothesis that CDO1, which metabolizes CSA from cysteine, would be aberrantly expressed in high-grade glioma.